No Data
lbx pharmacy chain joint stock (603883.SH): Currently, the company plans to open a total of 2,800 new stores this year.
Gelonghui December 4th, lbx pharmacy chain joint stock (603883.SH) stated at the performance briefing that since 2024, the company has continued to promote cost reduction and efficiency improvement. As of the end of the third quarter, a reduction of 0.1 billion yuan in fees has been achieved for the fiscal year 2024. Cost reduction and efficiency improvement mainly include the following four aspects. First, reduce rent and sublet, and cut down on rent. Second, reduce the speed of opening new stores, and exit some long-tail markets. Third, reduce management expenses such as travel expenses, business entertainment expenses, administrative office expenses, sales expenses. In the future, the company will continue to promote cost reduction and efficiency improvement. The company pays attention to the operational quality of existing stores, and improves the management and specialization of personnel, goods, and store operations through digitalization.
Earnings Growth of 1.6% Over 5 Years Hasn't Been Enough to Translate Into Positive Returns for LBX Pharmacy Chain (SHSE:603883) Shareholders
Zhong Sheng: Platforms that create opposition are garbage, we should respect entrepreneurs.
On November 19th, nongfu spring founder Zhong Shanshan attended an event in Ganzhou, jiangxi. When it comes to algorithm issues, Zhong Shanshan said that some people have used algorithms to block news from different perspectives. "Because once you open it, it's like this, it's like this when you open it". "A lot of evil is caused by humans. These people cause evil, especially by using science, technology, and technical capabilities, the evil caused is greater than that caused by ordinary people, this is a major evil", Zhong Shanshan calls on the government to come forward and ensure fairness. "I want to ask everyone, what is a rumor? You must create opposition, like Hollywood, you must have an antagonist, but there is no opposition".
LBX Pharmacy Chain's (SHSE:603883) Conservative Accounting Might Explain Soft Earnings
Donghai Securities: The chain pharmacy industry is accelerating integration, with continuous increase in concentration.
In 2023, the overall size of the pharmaceutical market is about 650 billion yuan, with a CAGR of 9.07% from 2015 to 2023, and the retail pharmacy terminal sales scale accounts for 29.3% of the national pharmaceutical sales terminal.
Earnings Miss: LBX Pharmacy Chain Joint Stock Company Missed EPS By 36% And Analysts Are Revising Their Forecasts
Insufficient Growth At LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Hampers Share Price
No Data
